Arena Pharmaceuticals, Inc.
ARNAN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
5
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ARNA News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Etrasimod
Ulcerative Colitis
Etrasimod 1 mg
Atopic Dermatitis
APD356-lorcaserin hydrochloride
Smoking Cessation
Olorinab
Crohn's Disease
APD125
Insomnia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Etrasimod | Phase 3 | Ulcerative Colitis | - | - |
Etrasimod 1 mg | Phase 2 | Atopic Dermatitis | - | - |
APD356-lorcaserin hydrochloride | Phase 2 | Smoking Cessation | - | - |
Olorinab | Phase 2 | Crohn's Disease | - | - |
APD125 | Phase 2 | Insomnia | - | - |
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply